Supreme Court asks drugs advisory body to decide fate of over 334 banned combination medicines

​​Companies can make and sell the 349 contested fixed dose combination drugs (FDCs) while Drugs Technical Advisory Board (DTAB) deliberates on the issue.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news